Impact of Non-Intubated Spontaneous Breathing Versus Intubated General Anesthesia in Thoracoscopic Surgery on Postoperative Venous Thromboembolism

Why It Matters

Reducing postoperative VTE improves patient outcomes and cuts costly complications, making anesthesia choice a strategic lever for thoracic surgery programs.

Key Takeaways

• Non-intubated anesthesia cut VTE incidence versus intubated group.
• Early ambulation achieved faster with non-intubated technique.
• Postoperative coagulation remained more stable without intubation.
• Study involved 55 lung cancer patients, retrospective design.
• Findings support broader adoption of non-intubated thoracic surgery.

Pulse Analysis

Venous thromboembolism remains a leading postoperative complication in thoracic procedures, driving morbidity, prolonged hospital stays, and increased health‑care costs. Traditional general anesthesia with endotracheal intubation can depress respiratory mechanics and delay mobilization, both of which exacerbate clot formation. In recent years, non‑intubated thoracoscopic surgery has emerged as a key component of Enhanced Recovery After Surgery (ERAS) protocols, promising reduced physiological stress and faster return to activity. Understanding whether this technique also mitigates VTE risk is critical for surgeons and anesthesiologists seeking evidence‑based pathways.

The Jinhua Central Hospital retrospective analysis compared 25 patients receiving non‑intubated anesthesia with 30 undergoing conventional intubated general anesthesia during lung cancer resections. Although baseline characteristics were balanced, the non‑intubated cohort ambulated earlier, passed flatus sooner, and displayed more stable postoperative coagulation profiles. Most notably, the incidence of clinically diagnosed VTE was lower, suggesting a protective effect. The study’s modest size and single‑center design limit generalizability, yet its findings align with prior reports linking early mobilization and reduced inflammatory response to fewer thrombotic events.

If corroborated by larger, prospective trials, the shift toward non‑intubated thoracic surgery could reshape peri‑operative standards, delivering both clinical and economic benefits. Lower VTE rates translate into fewer diagnostic imaging studies, anticoagulant prescriptions, and readmissions, directly impacting hospital budgets and patient quality of life. Moreover, the technique dovetails with minimally invasive trends, offering surgeons a pathway to maintain oncologic efficacy while enhancing recovery. Stakeholders should monitor emerging data and consider pilot programs that integrate non‑intubated protocols within existing ERAS frameworks.